Published in Gastrointest Endosc on April 21, 1993
A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? Gut (2004) 5.97
Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods. Gut (1995) 4.70
Polytetrafluoroethylene Ingestion as a Way to Increase Food Volume and Hence Satiety Without Increasing Calorie Content. J Diabetes Sci Technol (2016) 0.75
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods. Gut (1995) 4.70
Sedation for upper gastrointestinal endoscopy: results of a nationwide survey. Gut (1991) 3.14
Participation by women in behavior analysis. Behav Anal (1983) 2.95
14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. Lancet (1987) 2.68
Prevention of hypoxaemia during upper-gastrointestinal endoscopy by means of oxygen via nasal cannulae. Lancet (1987) 2.60
Gallstone dissolution in man using chenodeoxycholic acid. Lancet (1972) 2.55
Intravenous midazolam: a study of the degree of oxygen desaturation occurring during upper gastrointestinal endoscopy. Br J Clin Pharmacol (1987) 2.36
Depth of insertion at flexible sigmoidoscopy: implications for colorectal cancer screening and instrument design. Endoscopy (1999) 2.23
Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism. Br Med J (1980) 2.09
Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy. N Engl J Med (1975) 1.97
Simple half-gram stain for showing presence of Campylobacter pyloridis in sections. J Clin Pathol (1987) 1.84
Factors influencing human gallstone dissolution in monkey, dog, and human bile. Gut (1972) 1.73
Helicobacter pylori eradication in patients with peptic ulcer disease: clinical consequences and financial implications. Q J Med (1994) 1.67
Prospective evaluation of the McMurray test. Am J Sports Med (1993) 1.64
The value of radiology in predicting gallstone type when selecting patients for medical treatment. Gut (1975) 1.58
Anti-Helicobacter pylori therapy: clearance, elimination, or eradication? Lancet (1991) 1.57
Omeprazole and Helicobacter pylori: temporary suppression rather than true eradication. Aliment Pharmacol Ther (1991) 1.56
CRASH trial is based on problematic meta-analysis. BMJ (1999) 1.55
Long-term study of re-infection following successful eradication of Helicobacter pylori infection. Aliment Pharmacol Ther (2006) 1.54
Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers. J Clin Invest (1982) 1.54
Prospective audit of perforation rates following upper gastrointestinal endoscopy in two regions of England. Br J Surg (1995) 1.53
Colonoscopy--is sedation necessary and is there any role for intravenous propofol? Endoscopy (2000) 1.51
Outcome of endoscopy and barium radiography for acute upper gastrointestinal bleeding: controlled trial in 1037 patients. Br Med J (Clin Res Ed) (1982) 1.46
Effect of different doses of chenodeoxycholic acid on bile-lipid composition and on frequency of side-effects in patients with gallstones. Lancet (1974) 1.44
The present position concerning gallstone dissolution. Gut (1974) 1.41
Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med (2001) 1.41
Skeletal applications of videofluoroscopy. J Manipulative Physiol Ther (1990) 1.40
Protection of the bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine. Vet Rec (1995) 1.39
Tiguvon spot-on and flea control in dogs and cats. Vet Rec (1997) 1.39
Rowachol--a possible treatment for cholesterol gallstones. Gut (1979) 1.37
First clinical results with a real time, electronic imager as an aid to colonoscopy. Gut (1995) 1.31
Intraductal infusion of mono-octanoin: experience in 24 patients with retained common-duct stones. Lancet (1981) 1.30
Critical thresholds of intracranial pressure and cerebral perfusion pressure related to age in paediatric head injury. J Neurol Neurosurg Psychiatry (2005) 1.28
Measurement of exhaled chlorofluorocarbons. Lancet (1988) 1.27
Insufficient stocking of poisoning antidotes in hospital pharmacies. JAMA (1996) 1.27
Delayed release peppermint oil capsules (Colpermin) for the spastic colon syndrome: a pharmacokinetic study. Br J Clin Pharmacol (1984) 1.26
Lithogenic bile in patients with ileal dysfunction. Gut (1972) 1.26
Intravenous midazolam for upper gastrointestinal endoscopy: a study of 800 consecutive cases relating dose to age and sex of patient. Br J Clin Pharmacol (1987) 1.26
The [14C]-aminopyrine breath test. A comparison of different forms of analysis. Br J Clin Pharmacol (1979) 1.26
"Eradication" of Campylobacter pylori: are we being misled? Lancet (1988) 1.26
Non-radiological technique for three-dimensional imaging of endoscopes. Lancet (1993) 1.20
Pilot study of combination treatment for gall stones with medium dose chenodeoxycholic acid and a terpene preparation. Br Med J (Clin Res Ed) (1984) 1.19
Serum lipids in cholelithiasis: effect of chenodeoxycholic acid therapy. Br Med J (1973) 1.17
Inhibition of hepatic cholesterol synthesis and S-3-hydroxy-3-methylglutaryl-CoA reductase by mono and bicyclic monoterpenes administered in vivo. Biochem Pharmacol (1980) 1.11
Biotype and molecular fingerprints of metronidazole-resistant strains of Helicobacter pylori from antral gastric mucosa. J Med Microbiol (1993) 1.11
Helicobacter pylori infection in uraemic patients. Nephron (1991) 1.09
Telemedicine in gastrointestinal endoscopy. Endoscopy (2003) 1.06
Who is for supplemental oxygen? Gastrointest Endosc (1992) 1.05
Gall-stone dissolution and recurrence: are we being misled? Br Med J (Clin Res Ed) (1982) 1.04
Recording forces exerted on the bowel wall during colonoscopy: in vitro evaluation. Int J Med Robot (2005) 1.02
Liver structure and function in cholelithiasis: effect of chenodeoxycholic acid. Gut (1974) 1.02
The measurement of forces exerted during colonoscopy. Gastrointest Endosc (2000) 1.00
A double-blind placebo controlled study to examine effects of sucralfate on paracetamol absorption. Br J Clin Pharmacol (1985) 1.00
Helicobacter pylori infection treated with a tripotassium dicitrato bismuthate and metronidazole combination. Aliment Pharmacol Ther (1990) 0.99
Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis. Drugs (1996) 0.99
Hydrogen peroxide as a source of molecular oxygen for in vitro mammalian CNS preparations. Brain Res (1983) 0.98
Adjunct to bile-acid treatment for gall-stone dissolution: low-dose chenodeoxycholic acid combined with a terpene preparation. Br Med J (Clin Res Ed) (1981) 0.94
Salivary secretion of paracetamol in man. J Pharm Pharmacol (1987) 0.93
Colonoscopy aided by magnetic 3D imaging: is the technique sufficiently sensitive to detect differences between men and women? Med Biol Eng Comput (1999) 0.92
Gall stone dissolution in man using an essential oil preparation. Br Med J (1979) 0.92
Sleep-related breathing disorders following discharge from intensive care. Intensive Care Med (2000) 0.92
Sports Medicine: What family physicians see and what they need to learn. Can Fam Physician (1992) 0.91
The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occurring flavonoid. Biochem Pharmacol (1992) 0.90
Effect of ioglycamide (Biligram) on bile flow and biliary lipid secretion in man. Gut (1978) 0.89
The mechanism of cyclic monoterpene inhibition of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase in vivo in the rat. J Biol Chem (1982) 0.89
The inhibition of hepatic S-3-hydroxy-3-methylglutaryl-CoA reductase by 3,3,5-trimethylcyclohexanol and its mandelic acid ester, cyclandelate. Biochem Pharmacol (1983) 0.88
Tissue culture-propagated orf virus vaccine protects lambs from orf virus challenge. Vet Rec (1996) 0.88
Stones in the common bile duct: experience with medical dissolution therapy. Postgrad Med J (1985) 0.87
Alcohol and the gastrointestinal tract. Br Med Bull (1982) 0.87
Treatment of biliary duct stones with a terpene preparation. Br Med J (Clin Res Ed) (1981) 0.86
Ioglycamide (Biligram) studies in man--plasma binding, renal and biliary excretion studies in jaundiced and anicteric patients. Br J Radiol (1978) 0.86
Dietary cyclandelate decreases pre-established atherosclerosis in the rabbit. Atherosclerosis (1984) 0.86
Helicobacter pylori and metronidazole resistance. Lancet (1990) 0.85
Adaptive time-frequency analysis of knee joint vibroarthrographic signals for noninvasive screening of articular cartilage pathology. IEEE Trans Biomed Eng (2000) 0.85
Auditory display of knee-joint vibration signals. J Acoust Soc Am (2001) 0.85
Central airway compression. Anaesthetic and intensive care consequences. Anaesthesia (1997) 0.85
Outcome of children requiring intensive care following haematopoietic SCT for primary immunodeficiency and other non-malignant disorders. Bone Marrow Transplant (2011) 0.84
Analysis of knee joint sound signals for non-invasive diagnosis of cartilage pathology. IEEE Eng Med Biol Mag (1990) 0.84
Stones in common bile duct: non-operative management. Proc R Soc Med (1974) 0.84
The influence of age on the pharmacokinetics of paracetamol [proceedings]. Br J Clin Pharmacol (1979) 0.83
Screening of vibroarthrographic signals via adaptive segmentation and linear prediation modeling. IEEE Trans Biomed Eng (1996) 0.83
Monitoring during sedation for endoscopy. BMJ (1989) 0.83
Localization of knee joint cartilage pathology by multichannel vibroarthrography. Med Eng Phys (1995) 0.83
Single bolus injection or slow infusion for intravenous cholangiography? Measurement of iodipamide (Biligrafin) excretion using a rhesus monkey model. Br J Radiol (1972) 0.83
In vivo inhibition of hepatic lipogenesis in the rat by cyclandelate (3,3',5-trimethylcyclohexanylmandelate). Biochem Pharmacol (1983) 0.83
13C-urea breath test for Helicobacter pylori infection. Gut (1991) 0.81
Adaptive filtering, modelling and classification of knee joint vibroarthrographic signals for non-invasive diagnosis of articular cartilage pathology. Med Biol Eng Comput (1997) 0.81
Regulation of dolichol and of cholesterol biosynthesis in cholesterol-fed rabbits. Arch Biochem Biophys (1981) 0.80
Quantitative analysis of anterior cruciate ligament instability. Clin Biomech (Bristol, Avon) (1995) 0.80
A simple spectrophotometric method for measuring biliary ioglycamide (Biligram) concentration. Br J Radiol (1978) 0.80
Adaptive cancellation of muscle contraction interference in vibroarthrographic signals. IEEE Trans Biomed Eng (1994) 0.80
The effect of cyclandelate on cholesterol synthesis. Br J Clin Pract Suppl (1984) 0.80
Drip infusion cholangiography using iotroxamide. Double blind comparison with ioglycamide. Br J Radiol (1980) 0.79
Analysis of knee vibration signals using linear prediction. IEEE Trans Biomed Eng (1992) 0.79
Ioglycamide (Biligram) studies in man. Radiological opacification of the bile duct. A comparison of a number of different methods. Br J Radiol (1978) 0.79
Small bolus injections of intravenous midazolam for upper gastrointestinal endoscopy: a study of 788 consecutive cases. Br J Clin Pharmacol (1993) 0.79